Chemical and Pharmaceutical Bulletin p. 103 - 105 (2010)
Update date:2022-07-29
Topics:
Cassano, Roberta
Trombino, Sonia
Cilea, Alessia
Ferrarelli, Teresa
Muzzalupo, Rita
Picci, Nevio
In the present work, we report the synthesis of a new 5-amino salicylic acid (5-ASA) pro-prodrug, useful in Crohn disease treatment, and the evaluation of its antioxidant activity. Using as pharmacological carrier L-lysine amino acid and taking advantage of its intrinsic chemical reactivity, due to the presence of two amino groups, placed on the chiral center and in ε-position, we inserted trans-ferulic acid in ε-position, through amidation reaction, esterified with methanol the carboxylic group and, finally, submitted the free amino group to diazotation with 5-ASA, principal drug for inflammatory bowel diseases (IBD) care. All intermediates of synthesis and the final product (derivative A) were characterized with usual spectroscopic techniques, as FT-IR, GC/MS and 1HMNR. Finally, the derivative A antioxidant activity in inhibiting the lipid peroxidation, in rat-liver microsomal membranes, induced in vitro by two different sources of free radicals, 2,2′-azobis (2-amidinopropane) (AAPH) and tert-butyl hydroperoxide (tert-BOOH), was evaluated. Our pro-prodrug could be successfully applied in pharmaceutical field both as prodrug of 5-ASA than as carrier of trans-ferulic acid.
View MoreFuxin Jintelai Fluorin Chemical Co., Ltd.
Contact:+86-0418-8229599
Address:, 7th Huagong Road, Fluorine industry development zone (Yimatu Town,Fumeng County),Fuxin City, Liaoning Province, China
Contact:
Address:No.89,Xinhua Road, Langfang City,Hebei China
Zhonghao (dalian) Research and Design Institute of Chemical Industry Co., Ltd
Contact:+86 411 84674606
Address:201, Huangpu Road , Shahekou District, Dalian ,116023-China
Qingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Doi:10.1016/S0040-4039(00)88463-4
(1988)Doi:10.1002/asia.201900712
(2019)Doi:10.1016/0008-6215(89)85065-7
(1989)Doi:10.1021/acs.orglett.8b01386
(2018)Doi:10.1016/j.crci.2010.04.023
(2010)Doi:10.1007/s00726-009-0462-1
(2010)